Bethanechol Chloride Tablet
NDC Package 0832-0513-10
Package Information
Bethanechol Chloride tablets is a medication used to treat certain bladder problems such as the inability to urinate or empty the bladder completely due to certain causes (e.g., surgery, bladder muscle problems). This formulation utilizes a tablet delivery system. Marketed by Upsher-smith Laboratories, Llc, this product is identified by NDC 0832-0513 and is authorized under FDA application ANDA040636.
Identification & Billing
- RxCUI: 857321 - bethanechol chloride 10 MG Oral Tablet
- RxCUI: 857328 - bethanechol chloride 25 MG Oral Tablet
- RxCUI: 857336 - bethanechol chloride 5 MG Oral Tablet
- RxCUI: 857340 - bethanechol chloride 50 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0832 - Upsher-smith Laboratories, Llc
- 0832-0513 - Bethanechol Chloride
- 0832-0513-10 - 1000 TABLET in 1 BOTTLE
- 0832-0513 - Bethanechol Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0832-0513). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0832-0513-10 identifies a specific commercial package of 1000 tablet in 1 bottle of Bethanechol Chloride, a human prescription drug labeled by Upsher-smith Laboratories, Llc. This tablet is formulated for oral use and contains bethanechol chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Upsher-smith Laboratories, Llc on January 24, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat certain bladder problems such as the inability to urinate or empty the bladder completely due to certain causes (e.g., surgery, bladder muscle problems). It works by helping the bladder muscle to squeeze better, thereby improving your ability to urinate.
How is this Upsher-smith Laboratories, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00832051310. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.